Gros David-Alexandre C — SEC Form 4 filings

SEC reporting owner CIK 1644489. 4 Form 4 filings on record with FilingPulse; latest filed 2026-08-04.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2024-06-14 to 2026-08-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Eledon Pharmaceuticals, Inc. (ELDN)Chief Executive Officer, Director46

Form 4 filings — Gros David-Alexandre C

FiledFormIssuerReported transactionsSource
2026-08-044Eledon Pharmaceuticals, Inc. (ELDN)Grant/award (A): 354,454 @ $0 · Tax withholding (F): 194,791 @ $3.38EDGAR
2025-01-134Eledon Pharmaceuticals, Inc. (ELDN)Grant/award (A): 600,000 (derivative) @ $0 · Grant/award (A): 66,500 (derivative) @ $0EDGAR
2024-11-224Eledon Pharmaceuticals, Inc. (ELDN)Grant/award (A): 1,015,743 (derivative) @ $0EDGAR
2024-06-144Eledon Pharmaceuticals, Inc. (ELDN)Grant/award (A): 517,454 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1644489 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →